Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Charney, DS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 247 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Manji, HK; Drevets, WC; Charney, DS
      The cellular neurobiology of depression

      NATURE MEDICINE
    2. Jetty, PV; Charney, DS; Goddard, AW
      Neurobiology of generalized anxiety disorder

      PSYCHIATRIC CLINICS OF NORTH AMERICA
    3. Oren, DA; Zulman, DM; Needham, WE; Berman, RM; Anand, A; Charney, DS
      Visual impairment and patterns of winter seasonal depression: Seeing the light?

      JOURNAL OF VISUAL IMPAIRMENT & BLINDNESS
    4. Mason, JW; Wang, S; Yehuda, R; Riney, S; Charney, DS; Southwick, SM
      Psychogenic lowering of urinary cortisol levels linked to increased emotional numbing, and a shame-depressive syndrome in combat-related posttraumatic stress disorder

      PSYCHOSOMATIC MEDICINE
    5. Morgan, CA; Wang, S; Rasmusson, A; Hazlett, G; Anderson, G; Charney, DS
      Relationship among plasma cortisol, catecholamines, neuropeptide Y, and human performance during exposure to uncontrollable stress

      PSYCHOSOMATIC MEDICINE
    6. Krystal, JH; D'Souza, DC; Sanacora, G; Goddard, AW; Charney, DS
      Current perspectives on the pathophysiology of schizophrenia, depression, and anxiety disorders

      MEDICAL CLINICS OF NORTH AMERICA
    7. Charney, DS; Innis, RB; Nestler, EJ; Manji, HK
      Update: What's new in Biological Psychiatry

      BIOLOGICAL PSYCHIATRY
    8. Oren, DA; Charney, DS; Lavie, R; Sinyakov, M; Lubart, R
      Stimulation of reactive oxygen species production by an antidepressant visible light source

      BIOLOGICAL PSYCHIATRY
    9. Woods, SW; Stolar, M; Sernyak, MJ; Charney, DS
      Consistency of atypical antipsychotic superiority to placebo in recent clinical trials

      BIOLOGICAL PSYCHIATRY
    10. Goddard, AW; Mason, GF; Almai, A; Rothman, DL; Behar, KL; Petroff, OAC; Charney, DS; Krystal, JH
      Reductions in occipital cortex GABA levels in panic disorder detected withH-1-magnetic resonance spectroscopy

      ARCHIVES OF GENERAL PSYCHIATRY
    11. Bremner, JD; Narayan, M; Charney, DS
      Hippocampus and amygdala pathology in depression - Dr. Bremner and colleagues reply

      AMERICAN JOURNAL OF PSYCHIATRY
    12. Stine, SM; Grillon, CG; Morgan, CA; Kosten, TR; Charney, DS; Krystal, JH
      Methadone patients exhibit increased startle and cortisol response after intravenous yohimbine

      PSYCHOPHARMACOLOGY
    13. van Dyck, CH; Soares, JC; Tan, PZ; Staley, JK; Baldwin, RM; Amici, LA; Fu, X; Garg, PK; Seibyl, JP; Charney, DS; Innis, RB
      Equilibrium modeling of 5-HT2A receptors with [F-18]deuteroaltanserin and PET: Feasibility of a constant infusion paradigm

      NUCLEAR MEDICINE AND BIOLOGY
    14. Vythilingam, M; Anderson, ER; Goddard, A; Woods, SW; Staib, LH; Charney, DS; Bremner, JD
      Temporal lobe volume in panic disorder - a quantitative magnetic resonanceimaging study

      PSYCHIATRY RESEARCH-NEUROIMAGING
    15. Bremner, JD; Horti, A; Staib, LH; Zea-Ponce, Y; Soufer, R; Charney, DS; Baldwin, R
      Kinetic modeling of benzodiazepine receptor binding with PET and high specific activity [C-11]Iomazenil in healthy human subjects

      SYNAPSE
    16. Cramer, JA; Rosenheck, R; Xu, WC; Thomas, J; Henderson, W; Charney, DS
      Quality of life in schizophrenia: A comparison of instruments

      SCHIZOPHRENIA BULLETIN
    17. Oren, DA; Berman, RM; Anand, A; Charney, DS
      No effect of light on basal glucagon levels in winter seasonal depressivesand comparison subjects

      PSYCHIATRY RESEARCH
    18. Varrone, A; Fujita, M; Verhoeff, NPLG; Zoghbi, SS; Baldwin, RM; Rajeevan, N; Charney, DS; Seibyl, JP; Innis, RB
      Test-retest reproducibility of extrastriatal dopamine D-2 receptor imagingwith [I-123]epidepride SPECT in humans

      JOURNAL OF NUCLEAR MEDICINE
    19. van Dyck, CH; Tan, PZ; Baldwin, RM; Amici, LA; Garg, PK; Ng, CK; Soufer, R; Charney, DS; Innis, RB
      PET quantification of 5-HT2A receptors in the human brain: A constant infusion paradigm with [F-18]altanserin

      JOURNAL OF NUCLEAR MEDICINE
    20. Anand, A; Charney, DS
      Norepinephrine dysfunction in depression

      JOURNAL OF CLINICAL PSYCHIATRY
    21. Desan, PH; Oren, DA; Malison, R; Price, LH; Rosenbaum, J; Smoller, J; Charney, DS; Gelernter, J
      Genetic polymorphism at the CLOCK gene locus and major depression

      AMERICAN JOURNAL OF MEDICAL GENETICS
    22. Hoffman, RE; Boutros, NN; Hu, S; Berman, RM; Krystal, JH; Charney, DS
      Transcranial magnetic stimulation and auditory hallucinations in schizophrenia

      LANCET
    23. Vythilingam, M; Anderson, GM; Owens, MJ; Halaszynski, TM; Bremner, JD; Carpenter, LL; Heninger, GR; Nemeroff, CB; Charney, DS
      Cerebrospinal fluid corticotropin-releasing hormone in healthy humans: Effects of yohimbine and naloxone

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    24. Kaufman, J; Plotsky, PM; Nemeroff, CB; Charney, DS
      Effects of early adverse experiences on brain structure and function: Clinical implications

      BIOLOGICAL PSYCHIATRY
    25. Fujita, M; Charney, DS; Innis, RB
      Imaging serotonergic neurotransmission in depression: Hippocampal pathophysiology may mirror global brain alterations

      BIOLOGICAL PSYCHIATRY
    26. Charney, DS
      Bipolar disorder: Can studies of natural history help us define clinicallyand neurobiologically relevant subtypes?

      BIOLOGICAL PSYCHIATRY
    27. Charney, DS
      The use of placebos in randomized clinical trials of mood disorders: Well justified, but improvements in design are indicated

      BIOLOGICAL PSYCHIATRY
    28. Rasmusson, AM; Hauger, RL; Morgan, CA; Bremner, JD; Charney, DS; Southwick, SM
      Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD

      BIOLOGICAL PSYCHIATRY
    29. D'Souza, DC; Gil, R; Cassello, K; Morrissey, K; Abi-Saab, D; White, J; Sturwold, R; Bennett, A; Karper, LP; Zuzarte, E; Charney, DS; Krystal, JH
      IV glycine and oral D-cycloserine effects on plasma and CSF amino acids inhealthy humans

      BIOLOGICAL PSYCHIATRY
    30. Berman, RM; Narasimhan, M; Sanacora, G; Miano, AP; Hoffman, RE; Hu, XS; Charney, DS; Boutros, NN
      A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression

      BIOLOGICAL PSYCHIATRY
    31. Berman, RM; Cappiello, A; Anand, A; Oren, DA; Heninger, GR; Charney, DS; Krystal, JH
      Antidepressant effects of ketamine in depressed patients

      BIOLOGICAL PSYCHIATRY
    32. Bremner, JD; Innis, RB; White, T; Fujita, M; Silbersweig, D; Goddard, AW; Staib, L; Stern, E; Cappiello, A; Woods, S; Baldwin, R; Charney, DS
      SPECT [I-123]Iomazenil measurement of the benzodiazepine receptor in panicdisorder

      BIOLOGICAL PSYCHIATRY
    33. Krystal, JH; Bennett, A; Abi-Saab, D; Belger, A; Karper, LP; D'Souza, DC; Lipschitz, D; Abi-Dargham, A; Charney, DS
      Dissociation of ketamine effects on rule acquisition and rule implementation: Possible relevance to NMDA receptor contributions to executive cognitive functions

      BIOLOGICAL PSYCHIATRY
    34. Morgan, CA; Wang, S; Mason, J; Southwick, SM; Fox, P; Hazlett, G; Charney, DS; Greenfield, G
      Hormone profiles in humans experiencing military survival training

      BIOLOGICAL PSYCHIATRY
    35. Morgan, CA; Wang, S; Southwick, SM; Rasmusson, A; Hazlett, G; Hauger, RL; Charney, DS
      Plasma neuropeptide-Y concentrations in humans exposed to military survival training

      BIOLOGICAL PSYCHIATRY
    36. Anand, A; Charney, DS; Oren, DA; Berman, RM; Hu, XS; Cappiello, A; Krystal, JH
      Attenuation of the neuropsychiatric effects of ketamine with lamotrigine -Support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists

      ARCHIVES OF GENERAL PSYCHIATRY
    37. Anand, A; Verhoeff, P; Seneca, N; Zoghbi, SS; Seibyl, JP; Charney, DS; Innis, RB
      Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients

      AMERICAN JOURNAL OF PSYCHIATRY
    38. Bremner, JD; Innis, RB; Southwick, SM; Staib, L; Zoghbi, S; Charney, DS
      Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder

      AMERICAN JOURNAL OF PSYCHIATRY
    39. Bremner, JD; Narayan, M; Anderson, ER; Staib, LH; Miller, HL; Charney, DS
      Hippocampal volume reduction in major depression

      AMERICAN JOURNAL OF PSYCHIATRY
    40. Krystal, JH; D'Souza, DC; Petrakis, IL; Belger, A; Berman, RM; Charney, DS; Abi-Saab, W; Madonick, S
      NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders

      HARVARD REVIEW OF PSYCHIATRY
    41. Tan, PZ; Baldwin, RM; Van Dyck, CH; Al-Tikriti, M; Roth, B; Khan, N; Charney, DS; Innis, RB
      Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [F-18]altanserin in human and rodent

      NUCLEAR MEDICINE AND BIOLOGY
    42. Tan, PZ; Baldwin, RM; Soufer, R; Garg, PK; Charney, DS; Innis, RB
      A complete remote-control system for reliable preparation of [F-18]altanserin

      APPLIED RADIATION AND ISOTOPES
    43. Verhoeff, NPLG; Soares, JC; D'Souza, CD; Gil, R; Degen, K; Abi-Dargham, A; Zoghbi, SS; Fujita, M; Rajeevan, N; Seibyl, JP; Krystal, JH; van Dyck, CH; Charney, DS; Innis, RB
      [I-123]Iomazenil SPECT benzodiazepine receptor imaging in schizophrenia

      PSYCHIATRY RESEARCH-NEUROIMAGING
    44. Bremner, JD; Baldwin, R; Horti, A; Staib, LH; Ng, CK; Tan, PZ; Zea-Ponce, Y; Zoghbi, S; Seibyl, JP; Soufer, R; Charney, DS; Innis, RB
      Quantitation of benzodiazepine receptor binding with PET [C-11]iomazenil and SPECT [I-123]iomazenil: preliminary results of a direct comparison in healthy human subjects

      PSYCHIATRY RESEARCH-NEUROIMAGING
    45. Krystal, JH; Belger, A; D'Souza, DC; Anand, A; Charney, DS; Aghajanian, GK; Moghaddam, B
      Therapeutic implications of the hyperglutamatergic effects of NMDA antagonists

      NEUROPSYCHOPHARMACOLOGY
    46. Fujita, M; Seibyl, JP; Verhoeff, NPLG; Ichise, M; Baldwin, RM; Zoghbi, SS; Burger, C; Staley, JK; Rajeevan, N; Charney, DS; Innis, RB
      Kinetic and equilibrium analyses of [I-123]epidepride binding to striatal and extrastriatal dopamine D-2 receptors

      SYNAPSE
    47. Tan, PZ; Baldwin, RM; Fu, T; Charney, DS; Innis, RB
      Rapid synthesis of F-18 and H-2 dual-labeled altanserin, a metabolically resistant PET ligand for 5-HT2A receptors

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    48. Goddard, AW; Woods, SW; Money, R; Pande, AC; Charney, DS; Goodman, WK; Heninger, GR; Price, LH
      Effects of the CCKB antagonist CI-988 on responses to mCPP in generalized anxiety disorder

      PSYCHIATRY RESEARCH
    49. Ichise, M; Fujita, M; Seibyl, JP; Verhoeff, NPLG; Baldwin, RM; Zoghbi, SS; Rajeevan, N; Charney, DS; Innis, RB
      Graphical analysis and simplified quantification of striatal and extrastriatal dopamine D-2 receptor binding with [I-123]epidepride SPECT

      JOURNAL OF NUCLEAR MEDICINE
    50. Berman, RM; Charney, DS
      Models of antidepressant action

      JOURNAL OF CLINICAL PSYCHIATRY
    51. Fujita, M; Woods, SW; Verhoeff, NPLG; Abi-Dargham, A; Baldwin, RM; Zoghbi, SS; Soares, JC; Jatlow, PA; Krystal, JH; Rajeevan, N; Charney, DS; Seibyl, JP; Innis, RB
      Changes of benzodiazepine receptors during chronic benzodiazepine administration in humans

      EUROPEAN JOURNAL OF PHARMACOLOGY
    52. Duman, RS; Charney, DS
      New Vistas for an Old Neurotransmitter

      BIOLOGICAL PSYCHIATRY
    53. Southwick, SM; Bremner, JD; Rasmusson, A; Morgan, CA; Arnsten, A; Charney, DS
      Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder

      BIOLOGICAL PSYCHIATRY
    54. Charney, DS; Innis, RB; Nestler, EJ
      New requirements for manuscripts submitted to Biological Psychiatry: Informed consent and protection of subjects

      BIOLOGICAL PSYCHIATRY
    55. D'Souza, DC; Berman, RM; Krystal, JH; Charney, DS
      Symptom provocation studies in psychiatric disorders: Scientific value, risks, and future

      BIOLOGICAL PSYCHIATRY
    56. Southwick, SM; Morgan, CA; Charney, DS; High, JR
      Yohimbine use in a natural setting: Effects on posttraumatic stress disorder

      BIOLOGICAL PSYCHIATRY
    57. Delgado, PL; Miller, HL; Salomon, RM; Licinio, J; Krystal, JH; Moreno, FA; Heninger, GR; Charney, DS
      Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: Implications for the role of serotonin in the mechanism of antidepressant action

      BIOLOGICAL PSYCHIATRY
    58. Charney, DS; Innis, RB; Nestler, EJ; Davis, KL; Nemeroff, CB; Weinberger, DR
      Increasing public trust and confidence in psychiatric research

      BIOLOGICAL PSYCHIATRY
    59. Hoffman, RE; Boutros, NN; Berman, RM; Roessler, E; Belger, A; Krystal, JH; Charney, DS
      Transcranial magnetic stimulation of left temporoparietal cortex in three patients reporting hallucinated "voices"

      BIOLOGICAL PSYCHIATRY
    60. Duman, RS; Charney, DS
      Cell atrophy and loss in major depression

      BIOLOGICAL PSYCHIATRY
    61. Berman, RM; Anand, A; Cappiello, A; Miller, HL; Hu, XS; Oren, DA; Charney, DS
      The use of pindolol with fluoxetine in the treatment of major depression: Final results from a double-blind, placebo-controlled trial

      BIOLOGICAL PSYCHIATRY
    62. Anand, A; Darnell, A; Miller, HL; Berman, RM; Cappiello, A; Oren, DA; Woods, SW; Charney, DS
      Effect of catecholamine depletion on lithium-induced long-term remission of bipolar disorder

      BIOLOGICAL PSYCHIATRY
    63. Bremner, JD; Staib, LH; Kaloupek, D; Southwick, SM; Soufer, R; Charney, DS
      Neural correlates of exposure to traumatic pictures and sound in Vietnam combat veterans with and without posttraumatic stress disorder: A positron emission tomography study

      BIOLOGICAL PSYCHIATRY
    64. Gelernter, J; Southwick, S; Goodson, S; Morgan, A; Nagy, L; Charney, DS
      No association between D-2 dopamine receptor (DRD2) "A" system alleles, orDRD2 haplotypes, and posttraumatic stress disorder

      BIOLOGICAL PSYCHIATRY
    65. Kaufman, J; Charney, DS
      Neurobiological correlates of child abuse

      BIOLOGICAL PSYCHIATRY
    66. Charney, DS
      The National Bioethics Advisory Commission Report - The response of the Psychiatric Research Community is critical to restoring public trust

      ARCHIVES OF GENERAL PSYCHIATRY
    67. Berman, RM; Narasimhan, M; Miller, HL; Anand, A; Cappiello, A; Oren, DA; Heninger, GR; Charney, DS
      Transient depressive relapse induced by catecholamine depletion - Potential phenotypic vulnerability marker?

      ARCHIVES OF GENERAL PSYCHIATRY
    68. Sanacora, G; Mason, GF; Rothman, DL; Behar, KL; Hyder, F; Petroff, OAC; Berman, RM; Charney, DS; Krystal, JH
      Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy

      ARCHIVES OF GENERAL PSYCHIATRY
    69. Behar, KL; Rothman, DL; Petersen, KF; Hooten, M; Delaney, R; Petroff, OAC; Shulman, GI; Navarro, V; Petrakis, IL; Charney, DS; Krystal, JH
      Preliminary evidence of low cortical GABA levels in localized H-1-MR spectra of alcohol-dependent and hepatic encephalopathy patients

      AMERICAN JOURNAL OF PSYCHIATRY
    70. Bremner, JD; Narayan, M; Staib, LH; Southwick, SM; McGlashan, T; Charney, DS
      Neural correlates of memories of childhood sexual abuse in women with and without posttraumatic stress disorder

      AMERICAN JOURNAL OF PSYCHIATRY
    71. Krystal, JH; D'Souza, DC; Karper, LP; Bennett, A; Abi-Dargham, A; Abi-Saab, D; Cassello, K; Bowers, MB; Vegso, S; Heninger, GR; Charney, DS
      Interactive effects of subanesthetic ketamine and haloperidol in healthy humans

      PSYCHOPHARMACOLOGY
    72. Bremner, JD; Southwick, SM; Charney, DS
      The neurobiology of posttraumatic stress disorder: An integration of animal and human research

      POSTTRAUMATIC STRESS DISORDER
    73. BREMNER JD; KRYSTAL JH; PUTNAM FW; SOUTHWICK SM; MARMAR C; CHARNEY DS; MAZURE CM
      MEASUREMENT OF DISSOCIATIVE STATES WITH THE CLINICIAN-ADMINISTERED DISSOCIATIVE STATES SCALE (CADSS)

      Journal of traumatic stress
    74. RASMUSSON AM; SOUTHWICK SM; HAUGER RL; CHARNEY DS
      PLASMA NEUROPEPTIDE-Y (NPY) INCREASES IN HUMANS IN RESPONSE TO THE ALPHA(2) ANTAGONIST YOHIMBINE

      Neuropsychopharmacology
    75. SERNYAK MJ; GLAZER WM; HENINGER GR; CHARNEY DS; WOODS SW; PETRAKIS IL; KRYSTAL JH; PRICE LH
      NALTREXONE AUGMENTATION OF NEUROLEPTICS IN SCHIZOPHRENIA

      Journal of clinical psychopharmacology
    76. CAPPIELLO A; MCDOUGLE CJ; DELGADO PL; MALISON RT; JATLOW P; CHARNEY DS; HENINGER GR; PRICE LH
      LITHIUM AND DESIPRAMINE VERSUS DESIPRAMINE ALONE IN THE TREATMENT OF SEVERE MAJOR DEPRESSION - A PRELIMINARY-STUDY

      International clinical psychopharmacology
    77. SEIBYL JP; MAREK K; SHEFF K; ZOGHBI S; BALDWIN RM; CHARNEY DS; VANDYCK CH; INNIS RB
      IODINE-123-BETA-CIT AND IODINE-123-FPCIT SPECT MEASUREMENT OF DOPAMINE TRANSPORTERS IN HEALTHY-SUBJECTS AND PARKINSONS PATIENTS

      The Journal of nuclear medicine
    78. TAN PZ; SOARES J; BALDWIN RM; VANDYCK C; SOUFER R; SEIBYL JP; CHARNEY DS; INNIS RB
      H-2 AND F-18 DUAL-LABELED ALTANSERIN AS A METABOLICALLY RESISTANT PETLIGAND FOR SEROTONIN-2A (5-HT2A) RECEPTOR

      The Journal of nuclear medicine
    79. MALISON RT; PRICE LH; BERMAN R; PELTON GH; CARPENTER L; SANACORA G; OWENS MJ; NEMEROFF CB; RAJEEVAN N; BALDWIN RM; SEIBYL JP; INNIS RB; CHARNEY DS
      REDUCED MIDBRAIN SEROTONIN TRANSPORTER BINDING IN MAJOR DEPRESSION ASMEASURED BY [I-123] BETA-CIT SPECT

      The Journal of nuclear medicine
    80. ICHISE M; FUJITA M; SEIBYL JP; VERHOEFF NP; BALDWIN RM; ZOGHBI SS; RAJEEVAN N; CHARNEY DS; INNIS RB
      GRAPHICAL MODELING OF DOPAMINE D2 RECEPTOR-BINDING OF 1-123-EPIDEPRIDE TO ACCOUNT FOR LABELED LIPOPHILIC METABOLITES

      The Journal of nuclear medicine
    81. VANDYCK CH; TAN PZ; STALEY J; BALDWIN RM; ALTIKRITI M; GARG PK; NG CK; SOUFER R; CHARNEY DS; INNIS RB
      PET QUANTIFICATION OF 5-HT2A RECEPTORS - A CONSTANT INFUSION PARADIGMWITH [F-18] ALTANSERIN

      The Journal of nuclear medicine
    82. BREMNER JD; INNIS RB; WHITE T; FUJITA M; SILBERSWEIG D; GODDARD A; STAIB L; CAPPIELLO A; WOODS SW; BALDWIN R; CHARNEY DS
      SPECT MEASUREMENT OF BENZODIAZEPINE RECEPTOR-BINDING IN ANXIETY DISORDERS

      The Journal of nuclear medicine
    83. BREMNER JD; BALDWIN R; STAIB L; NG CK; HORTI A; SEIBYL JP; TAN P; ZEAPONCE Y; SOUFER R; CHARNEY DS; INNIS RB
      PET AND SPECT QUANTITATION OF BENZODIAZEPINE RECEPTOR-BINDING - A DIRECT HEAD-TO-HEAD COMPARISON

      The Journal of nuclear medicine
    84. CHARNEY DS
      CURRENT ISSUES IN ATTENTION-DEFICIT DISORDER - INTRODUCTION

      The Journal of clinical psychiatry
    85. CHARNEY DS
      MONOAMINE DYSFUNCTION AND THE PATHOPHYSIOLOGY AND TREATMENT OF DEPRESSION

      The Journal of clinical psychiatry
    86. OREN DA; CHARNEY DS
      SEASONS ON THE MIND

      Psychiatric annals
    87. WEINBERGER DR; CHARNEY DS
      BIOLOGICAL-PSYCHIATRY - A JOURNAL PROGRESS REPORT

      Biological psychiatry
    88. INNIS RB; NESTLER EJ; CHARNEY DS
      NEW RESEARCH SERIES

      Biological psychiatry
    89. MALISON RT; PRICE LH; BERMAN R; VANDYCK CH; PELTON GH; CARPENTER L; SANACORA G; OWENS MJ; NEMEROFF CB; RAJEEVAN N; BALDWIN RM; SEIBYL JP; INNIS RB; CHARNEY DS
      REDUCED BRAIN-SEROTONIN TRANSPORTER AVAILABILITY IN MAJOR DEPRESSION AS MEASURED BY [I-123] 2-BETA-CARBOMETHOXY-3-BETA-(4-IODOPHENYL)TROPANE AND SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY

      Biological psychiatry
    90. CHARNEY DS; INNIS RB; NESTLER EJ
      NEW LEADERSHIP FOR BIOLOGICAL PSYCHIATRY

      Biological psychiatry
    91. SANACORA G; GODDARD AW; GIL R; DSOUZA DC; ABISAAB W; PETROFF OAC; MATTSON R; MASON G; BEHAR KL; CIARCIA J; BERMAN R; CHARNEY DS; ROTHMAN D; KRYSTAL JH
      QUANTIFICATION OF CORTICAL GABA LEVELS IN NEUROPSYCHIATRIC PATIENTS

      Biological psychiatry
    92. ANAND A; INNIS RB; SEIBYL JP; MAREK KL; CHARNEY DS
      BRAIN SPECT IMAGING IN PARKINSONS-DISEASE ASSOCIATED WITH DEPRESSION

      Biological psychiatry
    93. BERMAN RM; BOUTROS N; NARASIMHAN M; SANACORA G; CHARNEY DS
      TRANSCRANIAL MAGNETIC STIMULATION IN TREATMENT-REFRACTORY DEPRESSION

      Biological psychiatry
    94. KRYSTAL JH; PETRAKIS IL; WEBB E; COONEY NL; KARPER LP; NAMANWORTH S; STETSON P; TREVISAN LA; CHARNEY DS
      DOSE-RELATED ETHANOL-LIKE EFFECTS OF THE NMDA ANTAGONIST, KETAMINE, IN RECENTLY DETOXIFIED ALCOHOLICS

      Archives of general psychiatry
    95. ABIDARGHAM A; GIL R; KRYSTAL J; BALDWIN RM; SEIBYL JP; BOWERS M; VANDYCK CH; CHARNEY DS; INNIS RB; LARUELLE M
      INCREASED STRIATAL DOPAMINE TRANSMISSION IN SCHIZOPHRENIA - CONFIRMATION IN A 2ND COHORT

      The American journal of psychiatry
    96. ABIDARGHAM A; KRYSTAL JH; ANJILVEL S; SCANLEY BE; ZOGHBI S; BALDWIN RM; RAJEEVAN N; ELLIS S; PETRAKIS IL; SEIBYL JP; CHARNEY DS; LARUELLE M; INNIS RB
      ALTERATIONS OF BENZODIAZEPINE RECEPTORS IN TYPE-II ALCOHOLIC SUBJECTSMEASURED WITH SPECT AND [I-123] IOMAZENIL

      The American journal of psychiatry
    97. KRYSTAL JH; KARPER LP; BENNETT A; DSOUZA DC; ABIDARGHAM A; MORRISSEY K; ABISAAB D; BREMNER JD; BOWERS MB; SUCKOW RF; STETSON P; HENINGER GR; CHARNEY DS
      INTERACTIVE EFFECTS OF SUBANESTHETIC KETAMINE AND SUBHYPNOTIC LORAZEPAM IN HUMANS

      Psychopharmacology
    98. ABIDARGHAM A; CHARNEY DS; KRYSTAL JH
      BENZODIAZEPINE RECEPTOR ANTAGONISTS - POSSIBLE USES IN THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS

      CNS DRUGS
    99. LARUELLE M; ABIDARGHAM A; KRYSTAL JH; CHARNEY DS; INNIS RB
      IN-VIVO EVALUATION OF DOPAMINE SYNAPTIC FUNCTION IN UNTREATED SCHIZOPHRENIC-PATIENTS

      Schizophrenia research
    100. ZUZARTE E; DSOUZA DC; GIL R; GENOVESE A; WHITE J; CHARNEY DS; KRYSTAL JH
      DOSE-RELATED ETHANOL EFFECTS IN SCHIZOPHRENIC-PATIENTS

      Schizophrenia research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/12/19 alle ore 14:46:57